Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Altimmune Inc

ALT
Current price
6.11 USD -0.38 USD (-5.86%)
Last closed 6.61 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 461 573 344 USD
Yield for 12 month +52.75 %
1Y
3Y
5Y
10Y
15Y
ALT
21.11.2021 - 28.11.2021

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland. Address: 910 Clopper Road, Gaithersburg, MD, United States, 20878

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

20.57 USD

P/E ratio

Dividend Yield

Current Year

+426 000 USD

Last Year

-68 000 USD

Current Quarter

+5 000 USD

Last Quarter

+37 000 USD

Current Year

-51 000 USD

Last Year

-136 000 USD

Current Quarter

-102 000 USD

Last Quarter

-1 853 000 USD

Key Figures ALT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -88 086 000 USD
Operating Margin TTM -535880 %
PE Ratio
Return On Assets TTM -29.48 %
PEG Ratio
Return On Equity TTM -54.46 %
Wall Street Target Price 20.57 USD
Revenue TTM 410 000 USD
Book Value 2.44 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -76.2 %
Dividend Yield
Gross Profit TTM -70 520 000 USD
Earnings per share -1.66 USD
Diluted Eps TTM -1.66 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ALT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ALT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 20.01.2017
Forward Annual Dividend Yield
Last Split Factor 1:30
Payout Ratio
Last Split Date 14.09.2018
Dividend Date 14.09.2018

Stock Valuation ALT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 866.9233
Price Sales TTM 1329.7028
Enterprise Value EBITDA -4.1998
Price Book MRQ 2.9184

Financials ALT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ALT

For 52 weeks

2.09 USD 14.84 USD
50 Day MA 7.55 USD
Shares Short Prior Month 23 064 510
200 Day MA 6.68 USD
Short Ratio 7.47
Shares Short 23 473 600
Short Percent 32.78 %

Dynamics of changes in the value of assets

Stocks


AAPL

AAPL

212.49 USD Apple Inc -1.32 (-0.62%)
Detailed analytics

ETF funds


S

SX7EEX

13.36 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) -0.53 (-3.54%)
Detailed analytics

Metals


Gold

2332.52 USD Gold +27.54 (+1.2%)
Detailed analytics